SARS-CoV-2 affects insulin release that caused by substantial impairment of pancreatic ilete brough on by the virus, as well as insulin resistance that caused by metablic and hormonal alteration and leads to occurrence of new-onset DM which subsequently considered as a major predictor of mortality associated with COVID-19 [23]. This evidence concerns the gene INS and COVID-19.